000 01303 a2200373 4500
005 20250516101002.0
264 0 _c20121130
008 201211s 0 0 eng d
022 _a1932-6203
024 7 _a10.1371/journal.pone.0039412
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSabha, Nesrin
245 0 0 _aInvestigation of the in vitro therapeutic efficacy of nilotinib in immortalized human NF2-null vestibular schwannoma cells.
_h[electronic resource]
260 _bPloS one
_c2012
300 _ae39412 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBlotting, Western
650 0 4 _aCell Cycle
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aHumans
650 0 4 _aNeurofibromin 2
_xgenetics
650 0 4 _aNeuroma, Acoustic
_xgenetics
650 0 4 _aPyrimidines
_xpharmacology
700 1 _aAu, Karolyn
700 1 _aAgnihotri, Sameer
700 1 _aSingh, Sanjay
700 1 _aMangat, Rupinder
700 1 _aGuha, Abhijit
700 1 _aZadeh, Gelareh
773 0 _tPloS one
_gvol. 7
_gno. 6
_gp. e39412
856 4 0 _uhttps://doi.org/10.1371/journal.pone.0039412
_zAvailable from publisher's website
999 _c21906107
_d21906107